Vol. 2, Issue 11, Part F (2016)
Microbial and antimicrobial resistance patterns in pneumonia: A regional cross-sectional analysis
Microbial and antimicrobial resistance patterns in pneumonia: A regional cross-sectional analysis
Author(s)
Dr. Julie Bania and Dr. Doddi Prabhakar
AbstractBackground: The global burden of pneumonia is exacerbated by the emergence of antimicrobial resistance. This study aimed to characterize the microbial and resistance profiles of pneumonia cases in a regional context, focusing on CAP, HAP, and VAP.
Materials and Methods: A cross-sectional study was conducted over a year, including 150 adults with radiologically confirmed pneumonia. Respiratory and blood samples were analyzed using standard culture techniques. Antibiotic susceptibility testing followed CLSI guidelines, with resistance mechanisms such as ESBL and MRSA identified through phenotypic assays.
Results: Gram-negative bacteria were predominant, with Klebsiella pneumoniae accounting for 40% of CAP and 30% of VAP cases. ESBL production was observed in 30.76% of HAP and 25% of VAP isolates. Recovery rates were highest in CAP (63%) but lowest in VAP (50%), which also had the highest mortality rate (45%).
Conclusion: The study highlights the predominance of gram-negative organisms and rising antimicrobial resistance in pneumonia. Regional data on resistance trends are essential for improving empirical therapy and patient outcomes.
How to cite this article:
Dr. Julie Bania, Dr. Doddi Prabhakar. Microbial and antimicrobial resistance patterns in pneumonia: A regional cross-sectional analysis. Int J Appl Res 2016;2(11):414-417.